Trial NCT02095145

Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance

This randomized phase II trial studies pomegranate-extract pill in preventing tumor growth in
patients with prostate cancer that is limited to a certain part of the body (localized), who
have chosen observation as their treatment plan. The use of pomegranate-extract pill may slow
disease progression in patients with localized prostate cancer.

Intervention

Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Pomegranate-Extract Pill

Condition

PSA Level Less Than or Equal to Fifteen, PSA Level Less Than Ten, Stage I Prostate Cancer AJCC v7, Stage II Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7

Investigators

See list of participating sites